GPER-1 Expression Decreases During Breast Cancer Tumorigenesis

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer

(2011) Atanas Ignatov et al.   BREAST CANCER RESEARCH AND TREATMENT

GPR30 Activation Opposes Estrogen-Dependent Uterine Growth via Inhibition of Stromal ERK1/2 and Estrogen Receptor Alpha (ERα) Phosphorylation Signals

(2011) Fei Gao et al.   ENDOCRINOLOGY

The GPER1 Agonist G-1 Attenuates Endothelial Cell Proliferation by Inhibiting DNA Synthesis and Accumulating Cells in the S and G2 Phases of the Cell Cycle

(2011) Anders Holm et al.   JOURNAL OF VASCULAR RESEARCH

Role of GPR30 in endometrial pathology after tamoxifen for breast cancer

(2010) Tanja Ignatov et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

The G Protein-Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor-Positive Breast Cancer Cells

(2010) E. A. Ariazi et al.   CANCER RESEARCH

Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21 and induction of G2 cell-cycle arrest

(2010) Q K Y Chan et al.   CELL DEATH AND DIFFERENTIATION

GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer

(2009) Hugo Arias-Pulido et al.   BREAST CANCER RESEARCH AND TREATMENT

Estrogen Signaling through the Transmembrane G Protein–Coupled Receptor GPR30

(2008) Eric R. Prossnitz et al.   Annual Review of Physiology

The ins and outs of GPR30: A transmembrane estrogen receptor

(2008) Eric R. Prossnitz et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY